Kairos Pharma, LTD. (KAPA) Insider Trading

Name: Kairos Pharma, LTD. (KAPA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Dec 30, 2025): Bhowmick Neil (Chief Scientific Officer): Grant/Award of 171,756 shares.

Get alerted when insiders trade KAPA

Email address

Loading company data...

Loading company details...